Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecogentus.net
CategoryBioTech
Phone650-543-4730
Employees
Founded2006
Descriptionpharmaceutical company

Offices

HQ
301 Ravenswood Avenue
Suite 100
Menlo Park, CA, 94025
USA

Funding

TOTAL $62.5M
FUNDING TOTAL $62.5M
Series C, 12/2007
Prospect Venture Partners
Apothecary Capital
Pinnacle Ventures
The Keffi Group
$62.5M

Tags

Cogentus Pharmaceuticals

Cogentus Pharmaceuticals, Inc., a pharmaceutical company, develops prescription pharmaceutical products in North America and Europe. It develops CGT-2168, an oral formulation that combines clopidogrel with a gastroprotectant, which reduces the gastrointestinal side effects associated with dual antiplatelet therapy. The company was founded in 2006 and is based in Menlo Park, California. On January 16, 2009, Cogentus Pharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.

Recent Milestones

Videos

Screenshots

Sources

  1. Cogentus Pharma raises $63M for blood thinners (venturebeat.com) [edit]
Edit This Page
Last Edited 3/8/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy